Co-Authors
This is a "connection" page, showing publications co-authored by Dave Singh and Rajeev Saggar.
Connection Strength
0.973
-
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19. Eur Respir J. 2021 10; 58(4).
Score: 0.973
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.